Business Context and Reporting Period
Scilex Holding Company filed this Form 8-K on July 5, 2023, reporting preliminary unaudited product sales results for June 2023, the quarter ended June 30, 2023, and year-to-date June 30, 2023. The filing primarily covers ZTlido and total product sales.
Key Financial Metrics
| Metric | June 2023 | Quarter Ended June 30, 2023 | Year-to-Date June 30, 2023 |
|---|---|---|---|
| ZTlido gross sales | $13.5–$14.5 million; up 82%–96% from $7.4 million | $37.5–$39.0 million; up 79%–86% from $21.0 million | $64.2–$67.3 million; up 63%–71% from $39.4 million |
| ZTlido net sales | $4.0–$5.1 million; up 21%–54% from $3.3 million | $11.2–$13.6 million; up 42%–72% from $7.9 million | $20.5–$23.0 million; up 39%–56% from $14.7 million |
| Total product gross sales | $14.0–$15.0 million; up 89%–103% from $7.4 million | $39.0–$40.0 million; up 86%–90% from $21.0 million | $65.6–$69.0 million; up 66%–75% from $39.4 million |
| Total product net sales | $4.2–$5.2 million; up 27%–57% from $3.3 million | $12.0–$14.0 million; up 52%–77% from $7.9 million | $20.8–$24.0 million; up 41%–63% from $14.7 million |
The filing does not provide preliminary figures for net income, operating income, cash flow, margins, debt, cash balances, or liquidity.
Material Changes Versus the Prior Comparable Period
- ZTlido gross sales increased substantially year over year across the monthly, quarterly, and year-to-date periods, with estimated growth of 63% to 96%.
- ZTlido net sales growth was lower than gross sales growth but remained positive, ranging from 21% to 72% across the reported periods.
- Total product gross sales and net sales also increased year over year across all periods, with total product net sales estimated to grow 41% to 63% year to date.
Guidance, Outlook, Risks, and Unusual Items
- These figures are preliminary estimates and are not formal forward-looking guidance.
- The Company had not completed its review, and its independent auditor had not reviewed or audited the results as of the filing date.
- Actual results may differ materially from the estimated ranges and may fall outside those ranges.
- Gross sales and net sales differ materially, indicating deductions from gross sales; the filing does not explain the specific components or expected sustainability of those deductions.
- Item 2.02 information is furnished rather than filed for purposes of Exchange Act Section 18 liability and is not incorporated by reference into other filings unless expressly stated.
Facts Investors Should Verify
- Final reported revenue and product sales in the subsequent quarterly filing.
- Whether the estimated ZTlido and total product sales ranges were achieved.
- Gross-to-net deductions, including rebates, discounts, returns, and chargebacks, and their effect on margins.
- Quarter-end cash, operating cash flow, debt obligations, and liquidity, which are not provided in this 8-K.
- Any updated management commentary regarding sales momentum, competition, product demand, and operating expenses.